Described are imino-azacycle-benzamide compounds that inhibit WDR5 and associated protein-protein interactions, pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating disorders and conditions in a subject.
描述了抑制 WDR5 和相关蛋白-蛋白相互作用的亚
氨基氮杂环苯甲酰胺化合物、包括这些化合物的药物组合物,以及使用这些化合物和组合物治疗受试者疾病和病症的方法。